Clinical Trial Update: Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of Atezolizumab with or without Tiragolumab for unresectable stage III non-small cell lung cancer. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: Alliance Foundation Trials, LLC. | Conditions: NSCLC | Phase 2 | Status: ACTIVE_NOT_RECRUITING